UniProt O75116
Rho-associated protein kinase 2 (O75116)
Rho-associated protein kinase 2 (UniProt O75116), EC 2.7.11.1: 22 experimental structures and 1 predicted model on GenesisL1, 14 ligands bound, 146 pockets. Binding sites, druggability and experiment against prediction (TM-score)…
- UniProt
- O75116
- Protein
- Rho-associated protein kinase 2
- EC
- 2.7.11.1
- Experimental structures
- 22
- Predicted models
- 1
- Ligands
- 14
- Pockets
- 146 · 11 records with a druggable one
Structures
23 records of O75116 in the MolNFT archive: 22 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4L6Q | ROCK2 in complex with benzoxaborole | x-ray diffraction | A, B | — | — |
| 4L6Q | ROCK2 in complex with benzoxaborole | x-ray diffraction | A, B | — | — |
| 4WOT | ROCK2 in complex with 1426382-07-1 | x-ray diffraction | A, B, C, D | — | — |
| 5U7Q | Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model… | x-ray diffraction | A, B, C, D | — | 20 (best 0.79) |
| 5U7Q | Identification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model… | x-ray diffraction | A, B, C, D | — | — |
| 5U7R | Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model… | x-ray diffraction | A, B, C, D | 81G | 20 (best 0.86) |
| 5U7R | Identification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model… | x-ray diffraction | A, B, C, D | 81G | — |
| 6ED6 | Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor | x-ray diffraction | A, B | J0P | 9 (best 0.72) |
| 6ED6 | Crystal structure of ROCK2 with a pyridinylbenzamide based inhibitor | x-ray diffraction | A, B | J0P | — |
| 6P5M | Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidi -Based Cdc7 inhibitor with… | x-ray diffraction | A, B, C, D | O1S | 20 (best 0.87) |
| 6P5M | Discovery of a novel, highly potent, and selective THIENO[3,2- D]PYRIMIDINONE-based CDC7 inhibitor… | x-ray diffraction | A, B, C, D | O1S | — |
| 6P5P | Discovery of a novel, highly potent, and selective THIENO[3,2- D]PYRIMIDINONE-based CDC7 inhibitor… | x-ray diffraction | A, B, C, D | O1V | — |
| 7JNT | Crystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a potent and selective… | x-ray diffraction | A, B, C, D, E, F, G, H | VFA, CL | 20 (best 0.82) |
| 7JNT | Crystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a potent and selective… | x-ray diffraction | A, B, C, D, E, F, G, H | VFA, CL | — |
| 7JOV | Crystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a phenylpyrazole amide… | x-ray diffraction | A, B, C, D, E, F, G, H | VFS, CL | — |
| 7JOV | Crystal structure of rho-associated protein kinase 2 (ROCK2) in complex with a phenylpyrazole amide… | x-ray diffraction | A, B, C, D, E, F, G, H | VFS, CL | — |
| 7P6N | ROCK2 in complex with compound 12 | x-ray diffraction | A, B, C, D, E, F, G, H | 5YS | — |
| 8GDS | Crystal structure of rho-associated protein kinase 2 (ROCK2) in complex with… | x-ray diffraction | A, B, C, D | Z8O, SO4 | 20 (best 0.75) |
| 8X8X | Crystal structure of ROCK2 with GNS-2591 inhibitor | x-ray diffraction | A, B | YDW, SO4 | 8 (best 0.71) |
| 8X8Y | Crystal structure of ROCK2 with GNS-2660 inhibitor | x-ray diffraction | A, B | YEA | 5 (best 0.70) |
| 8X8Z | Crystal structure of ROCK2 with GNS-2664 inhibitor | x-ray diffraction | A, B | YEI, SO4 | 6 (best 0.71) |
| 8X92 | Crystal structure of ROCK2 with GNS-2666 inhibitor | x-ray diffraction | A, B | YEW, SO4 | 7 (best 0.71) |
| O75116 | AlphaFold monomer V2.0 prediction for rho-associated protein kinase 2 (O75116) | predicted | A | — | 11 (best 0.66) |
Ligands
- CL · Chloride ion · in 4 records
- SO4 · Sulfate ion · in 4 records
- 81G · (1s,4s)-4-(4-fluorophenyl)-4-hydroxy-6'-(5-methyl-1H-pyrazol-4-yl)-1'H-spiro[cyclohexane-1,2'-thieno[3,2-d]pyrimidin]-4'(3'H)-one · in 2 records
- J0P · N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide · in 2 records
- O1S · 6-(5-methyl-1H-pyrazol-4-yl)-2-[(pyrrolidin-1-yl) methyl]thieno[3,2-d]pyrimidin-4(3H)-one · in 2 records
- VFA · N-[(3-methoxyphenyl)methyl]-5H-[1]benzopyrano[3,4-c]pyridine-8-carboxamide · in 2 records
- VFS · N-[(1S)-2-hydroxy-1-phenylethyl]-3-methoxy-4-(1H-pyrazol-4-yl)benzamide · in 2 records
- 5YS · ~{N}-[(1~{R})-1-(3-methoxyphenyl)ethyl]-4-pyridin-4-yl-piperidine-1-carboxamide · in 1 record
- O1V · 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one · in 1 record
- YDW · ~{N}-methyl-3-[[1-oxidanylidene-6-[5-(trifluoromethyl)-1~{H}-pyrazol-4-yl]isoquinolin-2-yl]methyl]benzamide · in 1 record
- YEA · 3-fluoranyl-~{N}-methyl-5-[[1-oxidanylidene-6-[5-(trifluoromethyl)-1~{H}-pyrazol-4-yl]isoquinolin-2-yl]methyl]benzamide · in 1 record
- YEI · ~{N}-methyl-3-[[6-(3-methyl-1,2-oxazol-4-yl)-1-oxidanylidene-isoquinolin-2-yl]methyl]benzamide · in 1 record
- YEW · ~{N}-methyl-3-[[6-(2-methylpyrazol-3-yl)-1-oxidanylidene-isoquinolin-2-yl]methyl]benzamide · in 1 record
- Z8O · 4-{4-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]phenyl}phthalazin-1(2H)-one · in 1 record
Experiment against prediction
- 7P6N chain H against the predicted model O75116: TM-score 0.99, RMSD 0.52 Å
- 7JNT chain B against the predicted model O75116: TM-score 0.99, RMSD 0.61 Å
- 7JNT chain B against the predicted model O75116: TM-score 0.99, RMSD 0.61 Å
- 4L6Q chain A against the predicted model O75116: TM-score 0.99, RMSD 0.63 Å
- 4L6Q chain A against the predicted model O75116: TM-score 0.99, RMSD 0.63 Å
- 7JOV chain A against the predicted model O75116: TM-score 0.99, RMSD 0.65 Å
- 7JOV chain A against the predicted model O75116: TM-score 0.99, RMSD 0.65 Å
- 7JOV chain D against the predicted model O75116: TM-score 0.99, RMSD 0.65 Å
- 7JOV chain D against the predicted model O75116: TM-score 0.99, RMSD 0.65 Å
- 7P6N chain B against the predicted model O75116: TM-score 0.99, RMSD 0.68 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.